14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $80.00 Thursday, 25th Apr 2024 AXSM stock ended at $71.52. This is 0.492% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 4.23% from a day low at $69.53 to a day high of $72.47.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Apr 25, 2024 $70.39 $72.47 $69.53 $71.52 410 645
Apr 24, 2024 $72.61 $73.14 $69.92 $71.17 577 335
Apr 23, 2024 $71.53 $74.33 $70.30 $73.08 699 006
Apr 22, 2024 $68.14 $71.30 $67.29 $71.10 486 091
Apr 19, 2024 $65.50 $68.14 $65.50 $67.90 882 843
Apr 18, 2024 $69.44 $70.08 $65.61 $65.72 834 137
Apr 17, 2024 $69.17 $70.77 $68.16 $69.71 385 143
Apr 16, 2024 $67.41 $70.05 $67.10 $68.81 457 490
Apr 15, 2024 $68.73 $69.30 $66.94 $68.21 423 167
Apr 12, 2024 $71.75 $71.75 $68.28 $69.15 584 054
Apr 11, 2024 $71.11 $71.95 $68.70 $71.73 766 355
Apr 10, 2024 $70.71 $71.60 $70.00 $70.97 571 873
Apr 09, 2024 $72.00 $73.47 $71.80 $72.64 370 496
Apr 08, 2024 $72.06 $72.74 $71.62 $72.11 391 453
Apr 05, 2024 $71.69 $73.49 $71.12 $72.25 369 336
Apr 04, 2024 $73.98 $74.98 $71.58 $72.17 393 102
Apr 03, 2024 $74.45 $74.45 $72.02 $73.50 623 574
Apr 02, 2024 $75.91 $76.12 $74.03 $74.56 645 879
Apr 01, 2024 $79.80 $80.00 $76.06 $76.99 585 127
Mar 28, 2024 $79.62 $79.98 $77.08 $79.80 487 583
Mar 27, 2024 $77.35 $79.25 $74.53 $79.17 473 749
Mar 26, 2024 $78.37 $79.50 $76.49 $76.72 572 373
Mar 25, 2024 $83.40 $83.89 $75.63 $77.35 1 398 281
Mar 22, 2024 $81.52 $82.00 $79.77 $80.66 579 993
Mar 21, 2024 $79.65 $80.98 $78.20 $80.86 839 367
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT